Side effects or other adverse events · children and adolescents with a diagnosis of autism
Galantamine plus risperidone may leads to higher adverse events (Side Effects Checklist) compared with placebo plus risperidone (low certainty).
1 finding from 1 review
Irritability · children and adolescents with a diagnosis of autism
1 finding from 1 review
Hyperactivity · children and adolescents with a diagnosis of autism
1 finding from 1 review
General health and function Not assessed · children and adolescents with a diagnosis of autism
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall autism features (total score of RLRS; raw score means; lower = better) · children and adolescents with a diagnosis of autism
1 finding from 1 review
Social communication (Social Relationships subscale of RLRS; raw score means; lower = better) · children and adolescents with a diagnosis of autism
1 finding from 1 review
Global improvement · Individuals with autism spectrum disorder
Music therapy probably leads to higher global improvement compared with placebo therapy or standard care (moderate certainty).
1 finding from 1 review
Social interaction · Individuals with autism spectrum disorder
1 finding from 1 review
Non‐verbal communication · Individuals with autism spectrum disorder
1 finding from 1 review
Verbal communication · Individuals with autism spectrum disorder
1 finding from 1 review
Quality of life · Individuals with autism spectrum disorder
1 finding from 1 review
Autism symptom severity Measured by: parent‐reported autism symptoms on standardised autism screening and diagnostic instruments (lower scores indicate less severe autism symptoms) · Individuals with autism spectrum disorder
1 finding from 1 review
Adverse events Any serious or non‐serious adverse event · Individuals with autism spectrum disorder
Music therapy showed no clear difference in adverse events Any serious or non‐serious adverse event compared with placebo therapy or standard care (moderate certainty).
1 finding from 1 review
All‐cause mortality · children aged between 6 months and 5 years
Vitamin A supplementation leads to lower all‐cause mortality compared with placebo or usual care (high certainty).
1 finding from 1 review
Vomiting · children aged between 6 months and 5 years
Vitamin A supplementation probably leads to higher vomiting compared with placebo or usual care (moderate certainty).
1 finding from 1 review
Vitamin A deficiency · children aged between 6 months and 5 years
Vitamin A supplementation probably leads to lower vitamin A deficiency compared with placebo or usual care (moderate certainty).
1 finding from 1 review
Mortality due to diarrhoea · children aged between 6 months and 5 years
Vitamin A supplementation leads to lower mortality due to diarrhoea compared with placebo or usual care (high certainty).
1 finding from 1 review
Mortality due to measles · children aged between 6 months and 5 years
Vitamin A supplementation showed no clear difference in mortality due to measles compared with placebo or usual care (low certainty).
1 finding from 1 review
Mortality due to LRTI · children aged between 6 months and 5 years
Vitamin A supplementation showed no clear difference in mortality due to LRTI compared with placebo or usual care (low certainty).
1 finding from 1 review
Diarrhoea incidence Mean episodes per child per year · children aged between 6 months and 5 years
Vitamin A supplementation may leads to lower diarrhoea incidence Mean episodes per child per year compared with placebo or usual care (low certainty).
1 finding from 1 review